Drug firm Hetero on Wednesday said it has launched generic oral antiviral drug Favipiravir used for the treatment of patients with mild to moderate COVID-19, in India under the brand name 'Favivir'......
The Hyderabad-based firm will first make the drug available in high case load areas of Maharashtra and Delhi under the brand Covifor. A single dose vial is likely to cost Rs 5,000-6000. ......
Hetero Healthcare on Wednesday said is set to deliver 20,000 vials of its antiviral drug Covifor (remdesivir) across the country for the treatment of COVID-19, at a maximum retail price of Rs 5,400......
Pharmaceutical companies, which are sending across medical aid for flood affected people in Jammu and Kashmir, claim to be facing difficulties in distribution of drugs M Srinivas Reddy, director......
Russian Direct Investment Fund (RDIF) and pharma firm Hetero have agreed to produce over 100 million doses per year in India of the Sputnik V vaccine against COVID-19, Russia's sovereign wealth......
Roche on Friday announced that it has granted a sub-licence to Hyderabad based Hetero Drugs for the production of oseltamivir (Tamiflu) as part of its continued efforts to increase and speed up......
Hetero Drugs ofHyderabad has bought over its joint venture partner's entire holding in Lyka Hetero Healthcare for an undisclosed sum.Lyka Hetero Healthcare was a 51:49 joint venture between the N I......
Hyderabad-based pharma company Hetero Drugs Ltd said on Monday that it had been chosen by the Clinton Research Foundation as one of the four Indian pharmaceutical companies that would supply......
Amid reports of bird flu cases in India, Hyderabad-based Hetero Drugs on Saturday said it has got an order from the Centre for an additional two lakh capsules of Tamiflu."We would be delivering......
Hetero Drugs, the Hyderabad-based active pharmaceutical ingredients and finished dosages manufacturer, has set up an equal stakes joint venture with Russian pharmaceutical major Makiz Pharma. As......